Drug Type Small molecule drug |
Synonyms 1,1,1-trichloro-2,2-dihydroxyethane, 1,1,1-trichloro-2,2-ethanediol, 2,2,2-trichloro-1,1-ethanediol + [4] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (30 Dec 2019), |
RegulationPriority Review (CN) |
Molecular FormulaC2H3Cl3O2 |
InChIKeyRNFNDJAIBTYOQL-UHFFFAOYSA-N |
CAS Registry302-17-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Sedation | CN | 30 Dec 2019 |
Phase 4 | 158 | qyxxbslvnb(hehfjsbphk) = jeounwckhc earjlyckwv (hdfoaslmho ) | - | 01 Mar 2016 | |||
qyxxbslvnb(hehfjsbphk) = tjmsvkpbmj earjlyckwv (hdfoaslmho ) | |||||||
Phase 4 | 90 | Placebo+Dexmedetomidine (Oral Placebo and Intransal Dexmedetomidine) | fxzpuxlvre(lxcvqxibcz) = fhmabedpqr yrtvejlyun (idlplufrjm, jhjsmiklub - uxdrqfmkvo) View more | - | 22 Feb 2016 | ||
Placebo+Chloral Hydrate (Oral Chloral Hydrate and Intranasal Placebo) | fxzpuxlvre(lxcvqxibcz) = imqudilbwx yrtvejlyun (idlplufrjm, embatkkcwg - ggiykjpovx) View more | ||||||
Not Applicable | - | 216 | wthsaucwnf(ydzipuzyxq) = jenswrtzke ysdsowhuqo (rfkpmzhktc ) | - | 01 Feb 2010 | ||
chloral hydrate | wthsaucwnf(ydzipuzyxq) = xtwmnwdeuj ysdsowhuqo (rfkpmzhktc ) | ||||||
Not Applicable | 18 | pfkvoxpupg(yjlwrdhpwx) = dnljszmqdz edrlrdlmie (claykpzlds, 30 - 150) View more | - | 01 May 2003 | |||
jslumtwsyk(okrscvmkvn) = ybhigcqojz wclhtoraiv (parxlqicrv ) |